Rotman Harris
Officer at CNTA
- Sold, on record
- $270k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Feb 1, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CNTACentessa Pharmaceuticals plcOfficer
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 144 notice CNTANoticeSep 20, 2023 2023
Filed to sell 37,484 shares ($244k)
Rotman Harris, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale CNTARoutineSep 20, 2023 same day
Sold 37,484 shares at $6.29 ($236k)
Rotman Harris, SVP Regulatory Affairs
10b5-1 planSold 52.8% of holdings ($446k position)33,500 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice CNTANoticeFeb 1, 2024 +134 days
Filed to sell 4,267 shares ($35k)
Rotman Harris, Officer
10b5-1 planFiling
- 4 Form 4 sale CNTARoutineFeb 1, 2024 same day
Sold 4,267 shares at $8.10 ($35k)
Rotman Harris, SVP Regulatory Affairs
10b5-1 planSold 6.4% of holdings ($542k position)62,625 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 2, 2024 | CNTA | SVP Regulatory Affairs | Form 4 sale | 4,267 | $35k | 6.4% | Routine | SEC |
| Feb 1, 2024 | Feb 1, 2024 | CNTA | Officer | Form 144 notice | 4,267 | $35k | Notice | SEC | |
| Sep 20, 2023 | Sep 22, 2023 | CNTA | SVP Regulatory Affairs | Form 4 sale | 37,484 | $236k | 52.8% | Routine | SEC |
| Sep 20, 2023 | Sep 20, 2023 | CNTA | Officer | Form 144 notice | 37,484 | $244k | Notice | SEC |